How did Puma Biotechnology's revenue and expenses shift in Q4 2024?

Puma Biotechnology's revenue and expenses in Q4 2024 showed a slight increase in revenue and significant R&D and marketing expenses, with a strong net income: 1. **Revenue Growth**: The company's total revenue for Q4 2024 was $59.08 million, representing a slight increase from the previous quarter. This indicates a positive trend in sales and market performance. 2. **Increased R&D Expenses**: Puma Biotechnology's R&D expenses were $15.17 million, reflecting a significant investment in research and development. This suggests the company is actively working on developing new products or improving existing ones, which is a positive sign for future growth. 3. **Sales and Marketing Expenses**: The company's selling, general, and administrative expenses were $16.62 million. This indicates a continued focus on marketing and sales efforts to support revenue growth. 4. **Net Income**: The net income for the quarter was $19.31 million, which is a strong indicator of profitability and the company's ability to generate returns from its operations. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |PBYI|PBYI.O|Puma Biotechnology|2023 Q4|318.8369603995719|1.2268E7|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q1|-443.6830835117773|-4815000|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q2|-313.02916274694263|-4529000|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q3|250.53485162180812|2.0317E7|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |PBYI|PBYI.O|Puma Biotechnology|2023 Q4|9.901789113056719|7.2178E7|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q1|-17.070582662245382|4.3766E7|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q2|-13.716830376777597|4.7083E7|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q3|43.52769263668116|8.0542E7|185| |code|Ticker|Name|Date|Cost of Goods Sold|Cost of Goods Sold YoY|market_code| |---|---|---|---|---|---|---| |PBYI|PBYI.O|Puma Biotechnology|2023 Q4|2.4323E7|44.470182941316224|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q1|1.0728E7|-18.837948252383114|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q2|1.0658E7|-10.112170026144893|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q3|2.9097E7|119.03794037940378|185| |code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code| |---|---|---|---|---|---|---| |PBYI|PBYI.O|Puma Biotechnology|2023 Q4|1.2873E7|-6.609112013929193|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q1|1.3587E7|6.933732095073193|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q2|1.3632E7|2.0588455491502584|185| |PBYI|PBYI.O|Puma Biotechnology|2024 Q3|1.2547E7|9.619080901625022|185|